Luminex Corporation (NASDAQ:LMNX) previous close was $36.81 while the outstanding shares total 45.89M. The firm has a beta of 0.58, a 12-month trailing P/E ratio of 73.91, and a growth ratio of 4.93. LMNX’s shares traded higher over the last trading session, gaining 0.19% on 05/27/21. The shares fell to a low of $36.76 before closing at $36.88. Intraday shares traded counted 0.53 million, which was 56.39% higher than its 30-day average trading volume of 1.21M. The stock’s Relative Strength Index (RSI) is 65.03, with weekly volatility at 0.32% and ATR at 0.21. The LMNX stock’s 52-week price range has touched low of $20.61 and a $41.69 high.
Investors have identified the Medical Instruments & Supplies company Luminex Corporation as an interesting stock but before investments are made there, an in-depth look at its trading activities will have to be conducted. The share is trading with a market value of around $1.74 billion, the company now has both obstacles and catalysts that affect them and they came from their mode of operations. With the company affected by events currently, it is a perfect time to analyze the numbers behind the firm in order to come up with a rather realistic picture of what this stock is.
Luminex Corporation (LMNX) Fundamentals that are to be considered.
When analyzing a stock, the first fundamental thing to take into account is the balance sheet. How healthy the balance sheet of a company is will determine if the company will be able to carry out all its financial and non-financial obligations and also keep the faith of its investors. In terms of their assets, the company currently has 481.79 million total, with 57.56 million as their total liabilities.
LMNX were able to record -34.88 million as free cash flow during the 08/09/2021 quarter of the year, this saw their quarterly net cash flow reduce by -37.85 million. In cash movements, the company had a total of -21.56 million as operating cash flow.
Potential earnings growth for Luminex Corporation (LMNX)
In order to determine the future investment potential for this stock, we will have to analyze key trends that affect it. During the 08/09/2021 quarter of the year, Luminex Corporation recorded a total of 110.69 million in revenue. This figure implies that they witnessed a quarterly year/year change in their earnings with 18.31% coming in sequential stages and their sales for the 08/09/2021 quarter reducing by -0.64%.
What matters though is how it ends. When the core data for the company is broken down, then the stock sounds interesting. The company spent 44.23 million trying to sell their products during the last quarter, with the result yielding a gross income of 66.46 million. This allows shareholders to hold on to 45.89M with the recently reported earning now reading 0.20 cents per share. This is a figure that compared to analyst’s prediction for their 08/09/2021 (0.19 cents a share).
Having a look at the company’s valuation, the company is expected to record 1.20 total earnings per share during the next fiscal year. It is very important though to remember that the importance of trend far outweighs that of outlook. This analysis has been great and getting further updates on LMNX sounds very interesting.
Is the stock of LMNX attractive?
In related news, SVP, Finance & CFO, CURRIE HARRISS T sold 5,325 shares of the company’s stock in a transaction that recorded on Mar 01. The sale was performed at an average price of 32.35, for a total value of 172,262. As the sale deal closes, the SVP, Global Sales & Cust Ops, Bennett Todd C. now sold 121,507 shares of the company’s stock, valued at 4,138,088. Also, Director, Eck Stephen L. bought 4,487 shares of the company’s stock in a deal that was recorded on Nov 25. The shares were price at an average price of 22.40 per share, with a total market value of 100,501. Following this completion of acquisition, the SR VP, GLOBAL MARKETING, Shapiro Eric now holds 14,179 shares of the company’s stock, valued at 569,429. In the last 6 months, insiders have changed their ownership in shares of company stock by 1.70%.
0 out of 4 analysts covering the stock have rated it a Buy, while 4 have maintained a Hold recommendation on Luminex Corporation. 0 analysts has assigned a Sell rating on the LMNX stock. The 12-month mean consensus price target for the company’s shares has been set at $34.50.